Category: Macular Degeneration Research Advances
With Gifts From Donors, AMDF Invests In Breakthrough Macular Degeneration Research
As we get ready to turn another year over, we’d like to pause and share a few of the standout highlights and breakthroughs that donor support, your support, helped achieve. In 2024, donor gifts were directed toward multiple research projects, and these investigations continue to evolve toward meaningful improvements in the lives of those affected…
Ocugen Clinical Trial Could Lead to Breakthrough One-Time Treatment for Advanced Dry Macular Degeneration
NORTHAMPTON, Ma., Dec. 19, 2023 — The American Macular Degeneration Foundation received news that the first patient has been dosed in a safety and efficacy clinical trial of a one-time gene therapy treatment for advanced dry macular degeneration (dry AMD), also known as Geographic Atrophy (GA). What’s exciting about this trial is that, if successful,…